KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $538.0 million.

  • Amgen's Shares Outstanding (Weighted Average) rose 18.62% to $538.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $538.0 million, marking a year-over-year increase of 18.62%. This contributed to the annual value of $538.0 million for FY2025, which is 18.62% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Shares Outstanding (Weighted Average) is $538.0 million, which was up 18.62% from $538.0 million recorded in Q3 2025.
  • Over the past 5 years, Amgen's Shares Outstanding (Weighted Average) peaked at $577.0 million during Q1 2021, and registered a low of $534.0 million during Q1 2023.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $544.9 million, with a median of $538.0 million in 2022.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first tumbled by 591.3% in 2022, then skyrocketed by 37.45% in 2024.
  • Quarter analysis of 5 years shows Amgen's Shares Outstanding (Weighted Average) stood at $570.0 million in 2021, then dropped by 5.61% to $538.0 million in 2022, then fell by 0.56% to $535.0 million in 2023, then rose by 0.37% to $537.0 million in 2024, then grew by 0.19% to $538.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $538.0 million in Q4 2025, compared to $538.0 million in Q3 2025 and $538.0 million in Q2 2025.